Changes in head and neck oncologic practice during the <scp>COVID</scp>‐19 pandemic

Brody, Robert M.; Albergotti, William Greer; Shimunov, David; Nicolli, Elizabeth A.; Patel, Urjeet A.; Harris, Brianna; Bur, Andrés M.

doi:10.1002/hed.26233

Cited by 45 publications

(63 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…1,2 COVID-19 has already had extraordinary effects on how multidisciplinary head and neck cancer (HNC) teams provide HNC patients in initial hotspots such as Wuhan, China and in Italy as well as the United States and throughout the world. [3][4][5] Following previous regional disasters such as Hurricane Katrina in 2008, there was an increase in incidence of patients presenting with advanced head and neck cancers. 6 We should be prepared for a similar surge in this patient population with the current pandemic after we pass the COVID-19 incidence peak.…”

Section: Introductionmentioning

confidence: 99%

Surge after the surge: Anticipating the increased volume and needs of patients with head and neck cancer after the peak in COVID‐19

2020

View full text Add to dashboard Cite

The novel coronavirus disease 2019 (COVID-19) pandemic continues to have extensive effects on public health as it spreads rapidly across the globe.Patients with head and neck cancer are a particularly susceptible population to these effects, and we expect there to be a potential surge in patients presenting with head and neck cancers after the surge in COVID-19. Furthermore, the impact of social distancing measures could result in a shift toward more advanced disease at presentation. With appropriate anticipation, multidisciplinary head and cancer teams could potentially minimize the impact of this surge and plan for strategies to provide optimal care for patients with head and neck cancer.

show abstract

Section: Introductionmentioning

confidence: 99%

Surge after the surge: Anticipating the increased volume and needs of patients with head and neck cancer after the peak in COVID‐19

2020

View full text Add to dashboard Cite

show abstract

“…27,28 We build upon this literature by conducting a direct comparison of the SNOT-22 and EPOS symptom criteria, focusing on CT scans in a broader-based population, and discretely incorporating the variable of symptom duration, which was not the focus of prior studies. Amid the current coronavirus disease 2019 (COVID-19) practice environment, [46][47][48][49][50][51][52][53] otolaryngologists have faced the challenge of making diagnoses without the typical reliance on concurrent fiberoptic exam. During telehealth encounters, we often need to proceed with medical decisions based on described symptoms and histories.…”

Section: Discussionmentioning

confidence: 99%

The Sinonasal Outcome Test–22 or European Position Paper: Which Is More Indicative of Imaging Results?

Zhou

Prince

Maxfield

et al. 2020

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

Objective The 22-item Sinonasal Outcome Test (SNOT-22) is a trusted measure of symptom severity in chronic rhinosinusitis. The European Position Paper on Rhinosinusitis (EPOS) provides widely accepted diagnostic criteria, which include sinonasal symptoms, their duration, and imaging results. Our objective was to compare these approaches to assessing symptoms to determine if either was more indicative of radiologic findings, to support decisions in telehealth. Study Design Observational outcomes study. Setting Tertiary care center. Methods In total, 162 consecutive patients provided a structured sinonasal history, completed the SNOT-22, and underwent sinus computed tomography (CT) within 1 month. SNOT-22 scores, EPOS-defined symptom sets, and Lund-Mackay results were assessed. To facilitate direct comparisons, we performed stepwise evaluations of sinonasal symptoms alone and combined with duration. The discriminatory capacity for imaging results was determined through areas under the receiver operating characteristic curves (ROC-AUC) for dichotomous outcomes and ordinal regression for multilevel outcomes. Results In ROC-AUC analyses, SNOT-22 and EPOS-defined symptoms had similar discriminatory capacity for Lund-Mackay scores, regardless of duration. Within ordinal regression analyses, SNOT-22 nasal scores were significantly associated with Lund-Mackay scores, while EPOS-defined nasal symptoms were not statistically significantly related. Conclusions SNOT-22 nasal scores and EPOS-defined nasal symptoms may have similar associations with imaging results when assessed via ROC-AUC, while SNOT-22 may have more association within ordinal data. Understanding the implications of discrete patterns of symptoms may confer benefit, particularly when in-person and fiberoptic exams are limited.

show abstract

“…Bazı baş-boyun kanserleri için de elektif olguların ertelenmesi söz konusudur. 9 Şiddetli akut solunum sendromu döneminde de KBB kliniklerinde hasta sayısında düşüşler kaydedilmiştir. 10 Fakat ertelendiğinde hastalığın evresinde ilerleme riski olan ya da daha ileri bir cerrahi tedavi gerektirebilecek olan özellikle yassı hücreli baş-boyun kanserlerinin tedavisine bu süreçte devam edilmesi önerilmektedir.…”

Section: Gereç Ve Yöntemlerunclassified

ENT Diseases Clinic Experience During COVID-19 Pandemic in a Tertiary Healthcare Institution

Duran¹,

Ant²,

Tunçcan³

et al. 2020

KBB ve BBC Dergisi

View full text Add to dashboard Cite

Tüm dünyada olduğu gibi ülkemizde de koronavirüs hastalığı-2019 [coronavirus disease-2019 (COVID-19)] salgınından etkilenen hasta sayısı artmaya devam etmektedir. Bir yandan bu olgularla ilgili süreçler devam ederken, diğer yandan özellikle kanser ile ilgili ertelenemez nitelikteki bazı kulak burun boğaz ve baş boyun cerrahisi (KBB-BBC) işlemlerinin devamı gerekmektedir. Bu çalışmada, COVID-19 salgını sırasında kliniğimizde yapılan düzenlemeleri ve cerrahi uygulanan olguların özelliklerini değerlendirmek ve klinik bir bakış açısı sağlamak amaçlanmıştır. Gereç ve Yöntemler: Üçüncü basamak tanı ve tedavi merkezi bünyesinde hizmet veren Sağlık Bilimleri Üniversitesi Dr. Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi, Kulak Burun Boğaz Hastalıkları Kliniğinin, 10 haftalık bir sürede (01 Mart 2020-10 Mayıs 2020) yapılan eğitim toplantı planları, çalışma planları, çalışma ortamlarındaki değişiklikler ve servise yatırılan 123 hastanın, hasta bilgi yönetim sistemi kayıtları incelendi. Riskli temasa maruz kalan personelin verileri değerlendirildi. Kliniğin çalışma düzeninde salgın süreci ile ilgili yapılan değişiklikler kaydedildi. Bulgular: Ülkemizde henüz ilk olgu bildirilmeden, başta eğitim planı ve malzeme temini olmak üzere klinik işleyişinde gerekli değişikliklerin yapıldığı görüldü. Salgının 4. haftasından itibaren personelin çapraz bulaşı engelleyecek şekilde ekiplere ayrılarak çalışma planı oluşturulduğu, yoğun temas olarak tanımlanan işlemler için koruyucu kabin temini ve uygun kişisel koruyucu ekipman (KKE) kullanımı sağlandığı ve böylece klinikteki sağlık çalışanlarının enfekte olmadığı görüldü. On haftalık sürenin ilk 16 gününde 60, sonraki 55 günde ise 63 olgunun servise yatırıldığı saptandı. Yatış endikasyonları ve yapılan işlemlerin, son 55 günlük dönemde malignite tanı, tetkik ve cerrahisi lehine değiştiği gözlendi. Sonuç: COVID-19 salgını sırasında üçüncü basamak bir sağlık merkezinin KBB-BBC kliniğinde yatan hasta sayısının azaldığı, ancak yapılan işlemlerin niteliğinin ve dolayısıyla bu kliniklerde hizmet veren sağlık çalışanlarının karşılaştıkları zorlukların/risklerin arttığı gözlenmiştir.

show abstract

Changes in head and neck oncologic practice during the COVID‐19 pandemic

Cited by 45 publications

References 13 publications

Surge after the surge: Anticipating the increased volume and needs of patients with head and neck cancer after the peak in COVID‐19

Surge after the surge: Anticipating the increased volume and needs of patients with head and neck cancer after the peak in COVID‐19

The Sinonasal Outcome Test–22 or European Position Paper: Which Is More Indicative of Imaging Results?

ENT Diseases Clinic Experience During COVID-19 Pandemic in a Tertiary Healthcare Institution

Contact Info

Product

Resources

About